Effects of acute and subchronic administration of dexefaroxan, an α2-adrenoceptor antagonist, on memory performance in young adult and aged rodents

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 1, 2002, Pages 187-196

  Chopin, Philippe ^a   Colpaert, Francis C ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; DEXEFAROXAN; DIAZEPAM; EXCITOTOXIN; SCOPOLAMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; COGNITION; CONTROLLED STUDY; MALE; MAZE TEST; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; OBJECT RELATION; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT; RECOGNITION; SHOCK; SPATIAL MEMORY; TASK PERFORMANCE; TRAINING;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AGING; ANIMALS; ANTI-ANXIETY AGENTS; AVOIDANCE LEARNING; BASAL NUCLEUS OF MEYNERT; BENZOPYRANS; CHOLINESTERASE INHIBITORS; COGNITION; DIAZEPAM; EXCITATORY AMINO ACID AGONISTS; IBOTENIC ACID; IMIDAZOLES; MALE; MAZE LEARNING; MEMORY; MICE; MUSCARINIC ANTAGONISTS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SCOPOLAMINE; TACRINE;

EID: 0036199264     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.1.187     Document Type: Article

References (38)

1. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance
2. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions
3. On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
4. Behavioral and biochemical effects of nucleus basalis magnocellularis lesions: Implications and possible relevance to understanding or treating Alzheimer's disease
5. Noradrenergic modulation of cognitive function: Clinical implications of anatomical, electrophysiological and behavioural studies in animal models
6. Reduction of long-term potentiation in the dentate gyrus of rat following selective depletion of monoamines
7. Agonists of cholinergic and noradrenergic receptors facilitate synergistically the induction of long-term potentiation in slices of rat visual cortex
8. Effects of four noncholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats
9. 2-adrenoceptor agonists and antagonists on circling behaviour in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway
10. Effects of putative α-adrenoceptor antagonists and of other compounds on the loss of the righting reflex and on exophthalmia induced by xylazine in the rat
11. Noradrenergic mechanisms in Parkinson's disease: A theory
12. Neurotransmitter deficits in Alzheimer's disease
13. Benzodiazepines, memory and mood: A review
14. 2-adrenoceptor antagonist, on cortico-basalis cholinergic deficits induced by cortical devascularization in the adult rat
15. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat
16. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data
17. 1-adrenoceptors
18. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: A critical involvement of the amygdala
19. Neurotransmitters and neuropeptides
20. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine)
21. Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole
22. The effects of a specific alpha2-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats
23. Reliability, distribution, and validity of age-related cognitive deficits in the Morris water maze
24. 2-adrenoceptor antagonists (+)-efaroxan and (±)-idazoxan against quinolinic acid-induced lesions of the rat striatum
25. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rat
26. Effects of RU 52583, an alpha 2-antagonist, on memory in rats with excitotoxic damage to the septal area
27. Spatial localization does not require the presence of local cues
28. Phencyclidine prevents spatial navigation and passive avoidance deficits in ibotenate lesioned rats
29. Are the neurochemical and behavioural changes induced by lesions of the nucleus basalis in the rat a model of Alzheimer's disease?
30. Convergent cholinergic activities in aging and Alzheimer's disease
31. Modulation of 5-hydroxytryptamine release by presynaptic inhibitory alpha 2-adrenoceptors in the human cerebral cortex
32. Neurotransmitter changes in Alzheimer's disease: Iq 37mplications to diagnostics and therapy
33. Clonidine impairs sustained attention and memory in Alzheimer's disease
34. Locus coeruleus-evoked responses in behaving rats: A clue to the role of noradrenaline in memory
35. Acetylcholine release in the rat prefrontal cortex in vivo: Modulation by α2-adrenoceptor agonists and antagonists
36. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species
37. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA
38. 2-adrenergic drugs on cortical high voltage spindles in rats